Cargando…
Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis
ABSTRACT: Cholesteatoma represents progressive expansion of the keratinizing squamous epithelium in the middle ear with subsequent chronic inflammation in subepithelial connective tissues. The hypothesis was tested that receptor for advanced glycation endproduct (RAGE) and its ligand, high-mobility...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333301/ https://www.ncbi.nlm.nih.gov/pubmed/25385222 http://dx.doi.org/10.1007/s00109-014-1217-3 |
_version_ | 1782358013483417600 |
---|---|
author | Szczepanski, Miroslaw J. Luczak, Michal Olszewska, Ewa Molinska-Glura, Marta Zagor, Mariola Krzeski, Antoni Skarzynski, Henryk Misiak, Jan Dzaman, Karolina Bilusiak, Mikolaj Kopec, Tomasz Leszczynska, Malgorzata Witmanowski, Henryk Whiteside, Theresa L. |
author_facet | Szczepanski, Miroslaw J. Luczak, Michal Olszewska, Ewa Molinska-Glura, Marta Zagor, Mariola Krzeski, Antoni Skarzynski, Henryk Misiak, Jan Dzaman, Karolina Bilusiak, Mikolaj Kopec, Tomasz Leszczynska, Malgorzata Witmanowski, Henryk Whiteside, Theresa L. |
author_sort | Szczepanski, Miroslaw J. |
collection | PubMed |
description | ABSTRACT: Cholesteatoma represents progressive expansion of the keratinizing squamous epithelium in the middle ear with subsequent chronic inflammation in subepithelial connective tissues. The hypothesis was tested that receptor for advanced glycation endproduct (RAGE) and its ligand, high-mobility box 1 (HMGB1), are overexpressed in cholesteatoma, and the RAGE/HMGB1 axis might contribute to its pathogenesis. Cholesteatoma samples (n = 36) and 27 normal skin specimens were studied by immunohistochemistry (IHC) for HMGB1 and RAGE expression. Effects of HMGB1 signaling on proliferation, migration, cytokine production, and apoptosis of human immortalized keratinocytes (HaCaTs) and normal keratinocytes were studied by quantitative reverse transcription (qRT)-PCR, IHC, Western blots, and flow cytometry after cell co-incubation with HMGB1. While all studied tissues expressed HMGB1, its expression was higher in cholesteatoma than in normal skin (p < 0.0001). All cases of cholesteatoma also showed elevated RAGE expression levels, and only 7/27 (26 %) of normal skin specimens were weakly positive for RAGE. Proliferation and migration of HaCaT cells incubated with HMGB1 were up-regulated (p < 0.05). HMGB1 also prevented HaCaT cell apoptosis and induced activation of several molecular signaling pathways in keratinocytes. The data suggest that in cholesteatoma, HMGB1 released from stressed or necrotic epithelial cells and binding to RAGE overexpressed in keratinocytes initiates molecular signaling that culminates in pro-inflammatory cytokine release and chronic inflammation. KEY MESSAGE: HMGB1 signaling engages multiple activation pathways in RAGE-positive keratinocytes. HMGB1 protects RAGE-positive keratinocytes from drug-induced apoptosis. Keratinocyte proliferation is controlled via RAGE and HMGB1 molecular signaling. Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00109-014-1217-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4333301 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-43333012015-02-24 Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis Szczepanski, Miroslaw J. Luczak, Michal Olszewska, Ewa Molinska-Glura, Marta Zagor, Mariola Krzeski, Antoni Skarzynski, Henryk Misiak, Jan Dzaman, Karolina Bilusiak, Mikolaj Kopec, Tomasz Leszczynska, Malgorzata Witmanowski, Henryk Whiteside, Theresa L. J Mol Med (Berl) Original Article ABSTRACT: Cholesteatoma represents progressive expansion of the keratinizing squamous epithelium in the middle ear with subsequent chronic inflammation in subepithelial connective tissues. The hypothesis was tested that receptor for advanced glycation endproduct (RAGE) and its ligand, high-mobility box 1 (HMGB1), are overexpressed in cholesteatoma, and the RAGE/HMGB1 axis might contribute to its pathogenesis. Cholesteatoma samples (n = 36) and 27 normal skin specimens were studied by immunohistochemistry (IHC) for HMGB1 and RAGE expression. Effects of HMGB1 signaling on proliferation, migration, cytokine production, and apoptosis of human immortalized keratinocytes (HaCaTs) and normal keratinocytes were studied by quantitative reverse transcription (qRT)-PCR, IHC, Western blots, and flow cytometry after cell co-incubation with HMGB1. While all studied tissues expressed HMGB1, its expression was higher in cholesteatoma than in normal skin (p < 0.0001). All cases of cholesteatoma also showed elevated RAGE expression levels, and only 7/27 (26 %) of normal skin specimens were weakly positive for RAGE. Proliferation and migration of HaCaT cells incubated with HMGB1 were up-regulated (p < 0.05). HMGB1 also prevented HaCaT cell apoptosis and induced activation of several molecular signaling pathways in keratinocytes. The data suggest that in cholesteatoma, HMGB1 released from stressed or necrotic epithelial cells and binding to RAGE overexpressed in keratinocytes initiates molecular signaling that culminates in pro-inflammatory cytokine release and chronic inflammation. KEY MESSAGE: HMGB1 signaling engages multiple activation pathways in RAGE-positive keratinocytes. HMGB1 protects RAGE-positive keratinocytes from drug-induced apoptosis. Keratinocyte proliferation is controlled via RAGE and HMGB1 molecular signaling. Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00109-014-1217-3) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2014-11-12 2015 /pmc/articles/PMC4333301/ /pubmed/25385222 http://dx.doi.org/10.1007/s00109-014-1217-3 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/4.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Original Article Szczepanski, Miroslaw J. Luczak, Michal Olszewska, Ewa Molinska-Glura, Marta Zagor, Mariola Krzeski, Antoni Skarzynski, Henryk Misiak, Jan Dzaman, Karolina Bilusiak, Mikolaj Kopec, Tomasz Leszczynska, Malgorzata Witmanowski, Henryk Whiteside, Theresa L. Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis |
title | Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis |
title_full | Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis |
title_fullStr | Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis |
title_full_unstemmed | Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis |
title_short | Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis |
title_sort | molecular signaling of the hmgb1/rage axis contributes to cholesteatoma pathogenesis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333301/ https://www.ncbi.nlm.nih.gov/pubmed/25385222 http://dx.doi.org/10.1007/s00109-014-1217-3 |
work_keys_str_mv | AT szczepanskimiroslawj molecularsignalingofthehmgb1rageaxiscontributestocholesteatomapathogenesis AT luczakmichal molecularsignalingofthehmgb1rageaxiscontributestocholesteatomapathogenesis AT olszewskaewa molecularsignalingofthehmgb1rageaxiscontributestocholesteatomapathogenesis AT molinskagluramarta molecularsignalingofthehmgb1rageaxiscontributestocholesteatomapathogenesis AT zagormariola molecularsignalingofthehmgb1rageaxiscontributestocholesteatomapathogenesis AT krzeskiantoni molecularsignalingofthehmgb1rageaxiscontributestocholesteatomapathogenesis AT skarzynskihenryk molecularsignalingofthehmgb1rageaxiscontributestocholesteatomapathogenesis AT misiakjan molecularsignalingofthehmgb1rageaxiscontributestocholesteatomapathogenesis AT dzamankarolina molecularsignalingofthehmgb1rageaxiscontributestocholesteatomapathogenesis AT bilusiakmikolaj molecularsignalingofthehmgb1rageaxiscontributestocholesteatomapathogenesis AT kopectomasz molecularsignalingofthehmgb1rageaxiscontributestocholesteatomapathogenesis AT leszczynskamalgorzata molecularsignalingofthehmgb1rageaxiscontributestocholesteatomapathogenesis AT witmanowskihenryk molecularsignalingofthehmgb1rageaxiscontributestocholesteatomapathogenesis AT whitesidetheresal molecularsignalingofthehmgb1rageaxiscontributestocholesteatomapathogenesis |